APO Research, Inc.

APO RESEARCH · REPORT

Metal-chelating Peptides(MCP)

Selected research

Market Outlook & Growth Opportunities

Global Metal-chelating Peptides(MCP) Market Outlook and Growth Opportunities 2026

Market perspective

The global Metal-chelating Peptides(MCP) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Metal-chelating Peptides(MCP) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metal-chelating Peptides(MCP) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metal-chelating Peptides(MCP) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Metal-chelating Peptides(MCP) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Metal-chelating Peptides(MCP) market include Bachem, Bio-Synthesis, CPC Scientific Inc, Creative Peptides, JPT Peptide Technologies, Pepscan, Allpeptide, WuXi TIDES and Wuhan Bioyeargene Biotechnology Co.,Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Metal-chelating Peptides(MCP) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metal-chelating Peptides(MCP) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metal-chelating Peptides(MCP) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metal-chelating Peptides(MCP) market size, projected growth trends, production technologies, key applications, and end-use industries.

Metal-chelating Peptides(MCP) Segment by Company

Bachem

Bio-Synthesis

CPC Scientific Inc

Creative Peptides

JPT Peptide Technologies

Pepscan

Allpeptide

WuXi TIDES

Wuhan Bioyeargene Biotechnology Co.,Ltd

Science Peptide

Genscript

Smartox Biotechnology

Rdcthera

NJ Bio

Metal-chelating Peptides(MCP) Segment by Type

NOTA

DTPA

DOTA

Other

Metal-chelating Peptides(MCP) Segment by Application

Molecular Imaging

Drug Delivery

Vaccine Development

Other

Metal-chelating Peptides(MCP) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Metal-chelating Peptides(MCP) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Metal-chelating Peptides(MCP) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Metal-chelating Peptides(MCP) significant trends, drivers, influence factors in global and regions.

6. To analyze Metal-chelating Peptides(MCP) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metal-chelating Peptides(MCP) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metal-chelating Peptides(MCP) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metal-chelating Peptides(MCP).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Metal-chelating Peptides(MCP) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Metal-chelating Peptides(MCP) industry.

Chapter 3: Detailed analysis of Metal-chelating Peptides(MCP) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Metal-chelating Peptides(MCP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Metal-chelating Peptides(MCP) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Metal-chelating Peptides(MCP) Industry Trends Table 2. Metal-chelating Peptides(MCP) Industry Drivers Table 3. Metal-chelating Peptides(MCP) Industry Opportunities and Challenges Table 4. Metal-chelating Peptides(MCP) Industry Restraints Table 5. Global Metal-chelating Peptides(MCP) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Metal-chelating Peptides(MCP) Revenue Share by Company (2021-2026) Table 7. Global Metal-chelating Peptides(MCP) Sales Volume by Company (Kg) & (2021-2026) Table 8. Global Metal-chelating Peptides(MCP) Sales Volume Share by Company (2021-2026) Table 9. Global Metal-chelating Peptides(MCP) Average Price (US$/g) of Company (2021-2026) Table 10. Global Metal-chelating Peptides(MCP) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Metal-chelating Peptides(MCP) Key Company Manufacturing Base & Headquarters Table 12. Global Metal-chelating Peptides(MCP) Company, Product Type & Application Table 13. Global Metal-chelating Peptides(MCP) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Metal-chelating Peptides(MCP) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of NOTA Table 18. Significant Companies of DTPA Table 19. Significant Companies of DOTA Table 20. Significant Companies of Other Table 21. Global Metal-chelating Peptides(MCP) Sales Volume by Type 2021 VS 2025 VS 2032 (Kg) Table 22. Global Metal-chelating Peptides(MCP) Sales Volume by Type (2021-2026) & (Kg) Table 23. Global Metal-chelating Peptides(MCP) Sales Volume by Type (2027-2032) & (Kg) Table 24. Global Metal-chelating Peptides(MCP) Sales Volume Share by Type (2021-2026) Table 25. Global Metal-chelating Peptides(MCP) Sales Volume Share by Type (2027-2032) Table 26. Global Metal-chelating Peptides(MCP) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Metal-chelating Peptides(MCP) Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Metal-chelating Peptides(MCP) Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Metal-chelating Peptides(MCP) Sales Value Share by Type (2021-2026) Table 30. Global Metal-chelating Peptides(MCP) Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Molecular Imaging Table 32. Significant Companies of Drug Delivery Table 33. Significant Companies of Vaccine Development Table 34. Significant Companies of Other Table 35. Global Metal-chelating Peptides(MCP) Sales Volume by Application 2021 VS 2025 VS 2032 (Kg) Table 36. Global Metal-chelating Peptides(MCP) Sales Volume by Application (2021-2026) & (Kg) Table 37. Global Metal-chelating Peptides(MCP) Sales Volume by Application (2027-2032) & (Kg) Table 38. Global Metal-chelating Peptides(MCP) Sales Volume Share by Application (2021-2026) Table 39. Global Metal-chelating Peptides(MCP) Sales Volume Share by Application (2027-2032) Table 40. Global Metal-chelating Peptides(MCP) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Metal-chelating Peptides(MCP) Sales Value by Application (2021-2026) & (US$ Million) Table 42. Global Metal-chelating Peptides(MCP) Sales Value by Application (2027-2032) & (US$ Million) Table 43. Global Metal-chelating Peptides(MCP) Sales Value Share by Application (2021-2026) Table 44. Global Metal-chelating Peptides(MCP) Sales Value Share by Application (2027-2032) Table 45. Global Metal-chelating Peptides(MCP) Sales by Region: 2021 VS 2025 VS 2032 (Kg) Table 46. Global Metal-chelating Peptides(MCP) Sales by Region (2021-2026) & (Kg) Table 47. Global Metal-chelating Peptides(MCP) Sales Market Share by Region (2021-2026) Table 48. Global Metal-chelating Peptides(MCP) Sales by Region (2027-2032) & (Kg) Table 49. Global Metal-chelating Peptides(MCP) Sales Market Share by Region (2027-2032) Table 50. Global Metal-chelating Peptides(MCP) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Metal-chelating Peptides(MCP) Sales Value by Region (2021-2026) & (US$ Million) Table 52. Global Metal-chelating Peptides(MCP) Sales Value Share by Region (2021-2026) Table 53. Global Metal-chelating Peptides(MCP) Sales Value by Region (2027-2032) & (US$ Million) Table 54. Global Metal-chelating Peptides(MCP) Sales Value Share by Region (2027-2032) Table 55. Global Metal-chelating Peptides(MCP) Market Average Price (US$/g) by Region (2021-2026) Table 56. Global Metal-chelating Peptides(MCP) Market Average Price (US$/g) by Region (2027-2032) Table 57. Global Metal-chelating Peptides(MCP) Sales by Country: 2021 VS 2025 VS 2032 (Kg) Table 58. Global Metal-chelating Peptides(MCP) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Metal-chelating Peptides(MCP) Sales by Country (2021-2026) & (Kg) Table 60. Global Metal-chelating Peptides(MCP) Sales Market Share by Country (2021-2026) Table 61. Global Metal-chelating Peptides(MCP) Sales by Country (2027-2032) & (Kg) Table 62. Global Metal-chelating Peptides(MCP) Sales Market Share by Country (2027-2032) Table 63. Global Metal-chelating Peptides(MCP) Sales Value by Country (2021-2026) & (US$ Million) Table 64. Global Metal-chelating Peptides(MCP) Sales Value Market Share by Country (2021-2026) Table 65. Global Metal-chelating Peptides(MCP) Sales Value by Country (2027-2032) & (US$ Million) Table 66. Global Metal-chelating Peptides(MCP) Sales Value Market Share by Country (2027-2032) Table 67. Bachem Company Information Table 68. Bachem Business Overview Table 69. Bachem Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 70. Bachem Metal-chelating Peptides(MCP) Product Portfolio Table 71. Bachem Recent Development Table 72. Bio-Synthesis Company Information Table 73. Bio-Synthesis Business Overview Table 74. Bio-Synthesis Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 75. Bio-Synthesis Metal-chelating Peptides(MCP) Product Portfolio Table 76. Bio-Synthesis Recent Development Table 77. CPC Scientific Inc Company Information Table 78. CPC Scientific Inc Business Overview Table 79. CPC Scientific Inc Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 80. CPC Scientific Inc Metal-chelating Peptides(MCP) Product Portfolio Table 81. CPC Scientific Inc Recent Development Table 82. Creative Peptides Company Information Table 83. Creative Peptides Business Overview Table 84. Creative Peptides Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 85. Creative Peptides Metal-chelating Peptides(MCP) Product Portfolio Table 86. Creative Peptides Recent Development Table 87. JPT Peptide Technologies Company Information Table 88. JPT Peptide Technologies Business Overview Table 89. JPT Peptide Technologies Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 90. JPT Peptide Technologies Metal-chelating Peptides(MCP) Product Portfolio Table 91. JPT Peptide Technologies Recent Development Table 92. Pepscan Company Information Table 93. Pepscan Business Overview Table 94. Pepscan Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 95. Pepscan Metal-chelating Peptides(MCP) Product Portfolio Table 96. Pepscan Recent Development Table 97. Allpeptide Company Information Table 98. Allpeptide Business Overview Table 99. Allpeptide Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 100. Allpeptide Metal-chelating Peptides(MCP) Product Portfolio Table 101. Allpeptide Recent Development Table 102. WuXi TIDES Company Information Table 103. WuXi TIDES Business Overview Table 104. WuXi TIDES Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 105. WuXi TIDES Metal-chelating Peptides(MCP) Product Portfolio Table 106. WuXi TIDES Recent Development Table 107. Wuhan Bioyeargene Biotechnology Co.,Ltd Company Information Table 108. Wuhan Bioyeargene Biotechnology Co.,Ltd Business Overview Table 109. Wuhan Bioyeargene Biotechnology Co.,Ltd Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 110. Wuhan Bioyeargene Biotechnology Co.,Ltd Metal-chelating Peptides(MCP) Product Portfolio Table 111. Wuhan Bioyeargene Biotechnology Co.,Ltd Recent Development Table 112. Science Peptide Company Information Table 113. Science Peptide Business Overview Table 114. Science Peptide Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 115. Science Peptide Metal-chelating Peptides(MCP) Product Portfolio Table 116. Science Peptide Recent Development Table 117. Genscript Company Information Table 118. Genscript Business Overview Table 119. Genscript Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 120. Genscript Metal-chelating Peptides(MCP) Product Portfolio Table 121. Genscript Recent Development Table 122. Smartox Biotechnology Company Information Table 123. Smartox Biotechnology Business Overview Table 124. Smartox Biotechnology Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 125. Smartox Biotechnology Metal-chelating Peptides(MCP) Product Portfolio Table 126. Smartox Biotechnology Recent Development Table 127. Rdcthera Company Information Table 128. Rdcthera Business Overview Table 129. Rdcthera Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 130. Rdcthera Metal-chelating Peptides(MCP) Product Portfolio Table 131. Rdcthera Recent Development Table 132. NJ Bio Company Information Table 133. NJ Bio Business Overview Table 134. NJ Bio Metal-chelating Peptides(MCP) Sales (Kg), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 135. NJ Bio Metal-chelating Peptides(MCP) Product Portfolio Table 136. NJ Bio Recent Development Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Metal-chelating Peptides(MCP) Distributors List Table 140. Metal-chelating Peptides(MCP) Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Metal-chelating Peptides(MCP) Product Image Figure 2. Global Metal-chelating Peptides(MCP) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metal-chelating Peptides(MCP) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Metal-chelating Peptides(MCP) Sales (2021-2032) & (Kg) Figure 5. Global Metal-chelating Peptides(MCP) Sales Average Price (US$/g) & (2021-2032) Figure 6. Global Metal-chelating Peptides(MCP) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. NOTA Image Figure 10. DTPA Image Figure 11. DOTA Image Figure 12. Other Image Figure 13. Global Metal-chelating Peptides(MCP) Sales Volume by Type (2021 VS 2025 VS 2032) & (Kg) Figure 14. Global Metal-chelating Peptides(MCP) Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Metal-chelating Peptides(MCP) Sales Volume Share by Type (2021-2032) Figure 16. Global Metal-chelating Peptides(MCP) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Metal-chelating Peptides(MCP) Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Metal-chelating Peptides(MCP) Sales Value Share by Type (2021-2032) Figure 19. Molecular Imaging Image Figure 20. Drug Delivery Image Figure 21. Vaccine Development Image Figure 22. Other Image Figure 23. Global Metal-chelating Peptides(MCP) Sales Volume by Application (2021 VS 2025 VS 2032) & (Kg) Figure 24. Global Metal-chelating Peptides(MCP) Sales Volume Share 2021 VS 2025 VS 2032 Figure 25. Global Metal-chelating Peptides(MCP) Sales Volume Share by Application (2021-2032) Figure 26. Global Metal-chelating Peptides(MCP) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 27. Global Metal-chelating Peptides(MCP) Sales Value Share 2021 VS 2025 VS 2032 Figure 28. Global Metal-chelating Peptides(MCP) Sales Value Share by Application (2021-2032) Figure 29. Global Metal-chelating Peptides(MCP) Sales by Region: 2021 VS 2025 VS 2032 (Kg) Figure 30. Global Metal-chelating Peptides(MCP) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 31. Global Metal-chelating Peptides(MCP) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 32. Global Metal-chelating Peptides(MCP) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 33. North America Metal-chelating Peptides(MCP) Sales Value (2021-2032) & (US$ Million) Figure 34. North America Metal-chelating Peptides(MCP) Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Europe Metal-chelating Peptides(MCP) Sales Value (2021-2032) & (US$ Million) Figure 36. Europe Metal-chelating Peptides(MCP) Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Asia-Pacific Metal-chelating Peptides(MCP) Sales Value (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Metal-chelating Peptides(MCP) Sales Value Share by Country (%), 2025 VS 2032 Figure 39. South America Metal-chelating Peptides(MCP) Sales Value (2021-2032) & (US$ Million) Figure 40. South America Metal-chelating Peptides(MCP) Sales Value Share by Country (%), 2025 VS 2032 Figure 41. Middle East & Africa Metal-chelating Peptides(MCP) Sales Value (2021-2032) & (US$ Million) Figure 42. Middle East & Africa Metal-chelating Peptides(MCP) Sales Value Share by Country (%), 2025 VS 2032 Figure 43. USA Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. USA Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. USA Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Canada Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Canada Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Canada Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Mexico Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Mexico Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Mexico Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Germany Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Germany Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Germany Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. France Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. France Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. France Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. U.K. Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. U.K. Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. U.K. Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Italy Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Italy Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Italy Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Spain Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Spain Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Spain Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Russia Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Russia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Russia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Netherlands Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Netherlands Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Netherlands Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Nordic Countries Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Nordic Countries Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Nordic Countries Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. China Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. China Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. China Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Japan Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Japan Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Japan Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. South Korea Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. South Korea Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. South Korea Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. India Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. India Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. India Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Australia Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Australia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Australia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Southeast Asia Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Southeast Asia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Southeast Asia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Brazil Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Brazil Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Brazil Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Argentina Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Argentina Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Argentina Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Chile Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Chile Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Chile Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Colombia Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Colombia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Colombia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Peru Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Peru Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Peru Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Saudi Arabia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Saudi Arabia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Israel Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Israel Arabia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Israel Arabia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. UAE Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. UAE Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. UAE Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Turkey Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Turkey Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Turkey Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Iran Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Iran Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Iran Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Egypt Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 125. Egypt Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 126. Egypt Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 127. Metal-chelating Peptides(MCP) Value Chain Figure 128. Manufacturing Cost Structure Figure 129. Metal-chelating Peptides(MCP) Sales Mode & Process Figure 130. Direct Comparison with Distribution Share Figure 131. Distributors Profiles Figure 132. Years Considered Figure 133. Research Process Figure 134. Key Executives Interviewed

Scope & coverage.

Types
  • NOTA
  • DTPA
  • DOTA
  • Other
Applications
  • Molecular Imaging
  • Drug Delivery
  • Vaccine Development
  • Other
Companies covered
  • Bachem
  • Bio-Synthesis
  • CPC Scientific Inc
  • Creative Peptides
  • JPT Peptide Technologies
  • Pepscan
  • Allpeptide
  • WuXi TIDES
  • Wuhan Bioyeargene Biotechnology Co.,Ltd
  • Science Peptide
  • Genscript
  • Smartox Biotechnology
  • Rdcthera
  • NJ Bio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Metal-chelating Peptides(MCP) Sales Value (2021-2032)
  4. 1.2.2 Global Metal-chelating Peptides(MCP) Sales Volume (2021-2032)
  5. 1.2.3 Global Metal-chelating Peptides(MCP) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Metal-chelating Peptides(MCP) Market Dynamics
  1. 2.1 Metal-chelating Peptides(MCP) Industry Trends
  2. 2.2 Metal-chelating Peptides(MCP) Industry Drivers
  3. 2.3 Metal-chelating Peptides(MCP) Industry Opportunities and Challenges
  4. 2.4 Metal-chelating Peptides(MCP) Industry Restraints
3 Metal-chelating Peptides(MCP) Market by Company
  1. 3.1 Global Metal-chelating Peptides(MCP) Company Revenue Ranking in 2025
  2. 3.2 Global Metal-chelating Peptides(MCP) Revenue by Company (2021-2026)
  3. 3.3 Global Metal-chelating Peptides(MCP) Sales Volume by Company (2021-2026)
  4. 3.4 Global Metal-chelating Peptides(MCP) Average Price by Company (2021-2026)
  5. 3.5 Global Metal-chelating Peptides(MCP) Company Ranking (2024-2026)
  6. 3.6 Global Metal-chelating Peptides(MCP) Company Manufacturing Base and Headquarters
  7. 3.7 Global Metal-chelating Peptides(MCP) Company Product Type and Application
  8. 3.8 Global Metal-chelating Peptides(MCP) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Metal-chelating Peptides(MCP) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Metal-chelating Peptides(MCP) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Metal-chelating Peptides(MCP) Market by Type
  1. 4.1 Metal-chelating Peptides(MCP) Type Introduction
  2. 4.1.1 NOTA
  3. 4.1.2 DTPA
  4. 4.1.3 DOTA
  5. 4.1.4 Other
  6. 4.2 Global Metal-chelating Peptides(MCP) Sales Volume by Type
  7. 4.2.1 Global Metal-chelating Peptides(MCP) Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Metal-chelating Peptides(MCP) Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Metal-chelating Peptides(MCP) Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Metal-chelating Peptides(MCP) Sales Value by Type
  11. 4.3.1 Global Metal-chelating Peptides(MCP) Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Metal-chelating Peptides(MCP) Sales Value by Type (2021-2032)
  13. 4.3.3 Global Metal-chelating Peptides(MCP) Sales Value Share by Type (2021-2032)
5 Metal-chelating Peptides(MCP) Market by Application
  1. 5.1 Metal-chelating Peptides(MCP) Application Introduction
  2. 5.1.1 Molecular Imaging
  3. 5.1.2 Drug Delivery
  4. 5.1.3 Vaccine Development
  5. 5.1.4 Other
  6. 5.2 Global Metal-chelating Peptides(MCP) Sales Volume by Application
  7. 5.2.1 Global Metal-chelating Peptides(MCP) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Metal-chelating Peptides(MCP) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Metal-chelating Peptides(MCP) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Metal-chelating Peptides(MCP) Sales Value by Application
  11. 5.3.1 Global Metal-chelating Peptides(MCP) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Metal-chelating Peptides(MCP) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Metal-chelating Peptides(MCP) Sales Value Share by Application (2021-2032)
6 Metal-chelating Peptides(MCP) Regional Sales and Value Analysis
  1. 6.1 Global Metal-chelating Peptides(MCP) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metal-chelating Peptides(MCP) Sales by Region (2021-2032)
  3. 6.2.1 Global Metal-chelating Peptides(MCP) Sales by Region: 2021-2026
  4. 6.2.2 Global Metal-chelating Peptides(MCP) Sales by Region (2027-2032)
  5. 6.3 Global Metal-chelating Peptides(MCP) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Metal-chelating Peptides(MCP) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Metal-chelating Peptides(MCP) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Metal-chelating Peptides(MCP) Sales Value by Region (2027-2032)
  9. 6.5 Global Metal-chelating Peptides(MCP) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Metal-chelating Peptides(MCP) Sales Value (2021-2032)
  12. 6.6.2 North America Metal-chelating Peptides(MCP) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Metal-chelating Peptides(MCP) Sales Value (2021-2032)
  15. 6.7.2 Europe Metal-chelating Peptides(MCP) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Metal-chelating Peptides(MCP) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Metal-chelating Peptides(MCP) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Metal-chelating Peptides(MCP) Sales Value (2021-2032)
  21. 6.9.2 South America Metal-chelating Peptides(MCP) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Metal-chelating Peptides(MCP) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Metal-chelating Peptides(MCP) Sales Value Share by Country, 2025 VS 2032
7 Metal-chelating Peptides(MCP) Country-level Sales and Value Analysis
  1. 7.1 Global Metal-chelating Peptides(MCP) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Metal-chelating Peptides(MCP) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Metal-chelating Peptides(MCP) Sales by Country (2021-2032)
  4. 7.3.1 Global Metal-chelating Peptides(MCP) Sales by Country (2021-2026)
  5. 7.3.2 Global Metal-chelating Peptides(MCP) Sales by Country (2027-2032)
  6. 7.4 Global Metal-chelating Peptides(MCP) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Metal-chelating Peptides(MCP) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Metal-chelating Peptides(MCP) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Metal-chelating Peptides(MCP) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Metal-chelating Peptides(MCP) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Metal-chelating Peptides(MCP) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bachem
  2. 8.1.1 Bachem Company Information
  3. 8.1.2 Bachem Business Overview
  4. 8.1.3 Bachem Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bachem Metal-chelating Peptides(MCP) Product Portfolio
  6. 8.1.5 Bachem Recent Developments
  7. 8.2 Bio-Synthesis
  8. 8.2.1 Bio-Synthesis Company Information
  9. 8.2.2 Bio-Synthesis Business Overview
  10. 8.2.3 Bio-Synthesis Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Bio-Synthesis Metal-chelating Peptides(MCP) Product Portfolio
  12. 8.2.5 Bio-Synthesis Recent Developments
  13. 8.3 CPC Scientific Inc
  14. 8.3.1 CPC Scientific Inc Company Information
  15. 8.3.2 CPC Scientific Inc Business Overview
  16. 8.3.3 CPC Scientific Inc Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 CPC Scientific Inc Metal-chelating Peptides(MCP) Product Portfolio
  18. 8.3.5 CPC Scientific Inc Recent Developments
  19. 8.4 Creative Peptides
  20. 8.4.1 Creative Peptides Company Information
  21. 8.4.2 Creative Peptides Business Overview
  22. 8.4.3 Creative Peptides Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Creative Peptides Metal-chelating Peptides(MCP) Product Portfolio
  24. 8.4.5 Creative Peptides Recent Developments
  25. 8.5 JPT Peptide Technologies
  26. 8.5.1 JPT Peptide Technologies Company Information
  27. 8.5.2 JPT Peptide Technologies Business Overview
  28. 8.5.3 JPT Peptide Technologies Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 JPT Peptide Technologies Metal-chelating Peptides(MCP) Product Portfolio
  30. 8.5.5 JPT Peptide Technologies Recent Developments
  31. 8.6 Pepscan
  32. 8.6.1 Pepscan Company Information
  33. 8.6.2 Pepscan Business Overview
  34. 8.6.3 Pepscan Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Pepscan Metal-chelating Peptides(MCP) Product Portfolio
  36. 8.6.5 Pepscan Recent Developments
  37. 8.7 Allpeptide
  38. 8.7.1 Allpeptide Company Information
  39. 8.7.2 Allpeptide Business Overview
  40. 8.7.3 Allpeptide Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Allpeptide Metal-chelating Peptides(MCP) Product Portfolio
  42. 8.7.5 Allpeptide Recent Developments
  43. 8.8 WuXi TIDES
  44. 8.8.1 WuXi TIDES Company Information
  45. 8.8.2 WuXi TIDES Business Overview
  46. 8.8.3 WuXi TIDES Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 WuXi TIDES Metal-chelating Peptides(MCP) Product Portfolio
  48. 8.8.5 WuXi TIDES Recent Developments
  49. 8.9 Wuhan Bioyeargene Biotechnology Co.,Ltd
  50. 8.9.1 Wuhan Bioyeargene Biotechnology Co.,Ltd Company Information
  51. 8.9.2 Wuhan Bioyeargene Biotechnology Co.,Ltd Business Overview
  52. 8.9.3 Wuhan Bioyeargene Biotechnology Co.,Ltd Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Wuhan Bioyeargene Biotechnology Co.,Ltd Metal-chelating Peptides(MCP) Product Portfolio
  54. 8.9.5 Wuhan Bioyeargene Biotechnology Co.,Ltd Recent Developments
  55. 8.10 Science Peptide
  56. 8.10.1 Science Peptide Company Information
  57. 8.10.2 Science Peptide Business Overview
  58. 8.10.3 Science Peptide Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Science Peptide Metal-chelating Peptides(MCP) Product Portfolio
  60. 8.10.5 Science Peptide Recent Developments
  61. 8.11 Genscript
  62. 8.11.1 Genscript Company Information
  63. 8.11.2 Genscript Business Overview
  64. 8.11.3 Genscript Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Genscript Metal-chelating Peptides(MCP) Product Portfolio
  66. 8.11.5 Genscript Recent Developments
  67. 8.12 Smartox Biotechnology
  68. 8.12.1 Smartox Biotechnology Company Information
  69. 8.12.2 Smartox Biotechnology Business Overview
  70. 8.12.3 Smartox Biotechnology Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Smartox Biotechnology Metal-chelating Peptides(MCP) Product Portfolio
  72. 8.12.5 Smartox Biotechnology Recent Developments
  73. 8.13 Rdcthera
  74. 8.13.1 Rdcthera Company Information
  75. 8.13.2 Rdcthera Business Overview
  76. 8.13.3 Rdcthera Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Rdcthera Metal-chelating Peptides(MCP) Product Portfolio
  78. 8.13.5 Rdcthera Recent Developments
  79. 8.14 NJ Bio
  80. 8.14.1 NJ Bio Company Information
  81. 8.14.2 NJ Bio Business Overview
  82. 8.14.3 NJ Bio Metal-chelating Peptides(MCP) Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 NJ Bio Metal-chelating Peptides(MCP) Product Portfolio
  84. 8.14.5 NJ Bio Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Metal-chelating Peptides(MCP) Value Chain Analysis
  2. 9.1.1 Metal-chelating Peptides(MCP) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Metal-chelating Peptides(MCP) Sales Mode & Process
  6. 9.2 Metal-chelating Peptides(MCP) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Metal-chelating Peptides(MCP) Distributors
  9. 9.2.3 Metal-chelating Peptides(MCP) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.